Travere Therapeutics to Present at Upcoming Investor Conferences

SAN DIEGO, June 01, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the following upcoming conferences:

William Blair 43^rd Annual Growth Stock Conference
Tuesday, June 6, 2023, at 12:40 p.m. CT

Jefferies Healthcare Conference
Wednesday, June 7, 2023, at 11:00 a.m. ET

Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations. Replays will be available for up to 30 days following each event.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.

You May Also Be Interested In

• Result of the auction of 2.25 per cent DGB 2035 and 0.25 per cent DGB 2052
• AFL attracts strong investor interest in new EUR 500m 8-year Sustainability Bond
• Levicept Announces Attendance at Cantor and Jefferies Global Healthcare Conferences